Showing results (2741-2750 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|September 23, 2008
Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control studyMaria P Imbergamo, Marco C Amato, Giovanna Sciortino, et al.Clinical Therapeutics|September 23, 2008
Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medicationsJoel F Farley, Richard R Cline, Jon C Schommer, et al.Clinical Therapeutics|September 23, 2008
Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care databaseKenneth C Jackson, Xiaoming Sheng, Richard E Nelson, et al.Clinical Therapeutics|August 12, 2008
Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsyElinor Ben-Menachem, Josemir W Sander, Hermann Stefan, et al.Clinical Therapeutics|August 12, 2008
Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infectionSharon S Lieberman-Blum, Horatio B Fung, Juan C BandresClinical Therapeutics|August 12, 2008
Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover studyWei Zhang, Sheng Deng, Xiao-Ping Chen, et al.Clinical Therapeutics|August 12, 2008
Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: a preliminary monocentric studyNicolas André, Angelique Rome, Carole Coze, et al.Clinical Therapeutics|August 12, 2008
Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorderFrank D Gianfrancesco, Martha Sajatovic, Krithika Rajagopalan, et al.Clinical Therapeutics|August 22, 2009
Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment periodHans Georg Kress, Anna Orońska, Zbigniew Kaczmarek, et al.Clinical Therapeutics|August 22, 2009
Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studiesStephen Daniels, Jeffery Robbins, Christine R West, et al.Pageof 678